-
-
Call more information
660-596-2224 -
Anesthesiology September 2024, Vol. 141, A13–A15. Video versus direct laryngoscopy for urgent intubation of newborn infants. N Engl J Med 2024; 390:1885–94. PMID: 38709215. In contrast to availability in adults and children, only limited data on the efficacy of video laryngoscopy for neonatal intubation area are available. This single-center trial (tertiary Irish center) randomized neonates (any […]
Read MoreAuthors: Erik Anderson, M.D. et al Anesthesiology September 2024, Vol. 141, 568–569.ed into a pulmonary vein in a patient with undiagnosed partial anomalous pulmonary venous return. A post procedure chest X-ray revealed that the catheter tip was in the hilum of the left lung. A blood gas drawn from this misplaced catheter, a preexisting dialysis catheter […]
Read MoreAuthors: Martin Dworschak, M.D., M.B.A.; Ekaterina Pataraia, M.D., M.B.A. Anesthesiology August 2024. To the Editor: We read with great interest the article by Soehle et al., recently published in this journal. They used three devices employing near-infrared spectroscopy technology (i.e., the INVOS 5100 C and the INVOS 7100 [Medtronic Inc., USA] and the ForeSight Elite [Edwards Lifescience Corp., […]
Read MoreAutors: Martin Soehle, M.D., Ph.D., M.H.B.A. et al Anesthesiology August 2024. In Reply: We thank Drs. Dworschak and Pataraia for their interest and thoughtful comments regarding our recent publication on the effect of brain death on regional cerebral oxygenation (rScO2) as determined by near-infrared spectroscopy. Their concerns relate to our statement that brain perfusion was absent during […]
Read MoreAnesthesiology September 2024, Vol. 141, A13–A15. Distinct μ-opioid ensembles trigger positive and negative fentanyl reinforcement. Nature 2024; 630:141–8. PMID: 38778097 The potent µ-opioid receptor (µOR)–specific agonist, fentanyl, has devastating consequences on public health, increasing opioid addiction-related deaths. Fentanyl is highly addictive, with robust withdrawal symptoms leading to negative reinforcement behaviors where individuals retake the drug to […]
Read MoreWe are seeking a dedicated anesthesiologist to join our all-anesthesiologist group. Our team will consist of 4 full-time providers and 1 for vacation relief, managing 3 operating rooms. Position Highlights: Zero call for 3 weeks, followed by 1 week of call without daytime work only call after 7 PM therefore you may not work the […]
Read MoreAuthors: Adam Warrick, M.D. et al Anesthesiology August 2024. These images demonstrate sublingual hematoma progression in a patient presenting for repeat laparoscopy after cholecystectomy complicated by incomplete hemostasis (fig.1, A to C, arrows). On postoperative day one, the patient reported frenulum tenderness, purpura, and an expanding mass beneath her tongue (fig.1, A). Otolaryngology evaluation was obtained, […]
Read MoreAuthors: Benjamin Bergis, M.D., M.Sc. et al Anesthesiology September 2024, Vol. 141, 554–565. Background Hemorrhagic shock (HS) and rhabdomyolysis (RM) are two important risk factors for acute kidney injury after severe trauma; however, the effects of the combination of RM and HS on kidney function are unknown. The purpose of this study was to determine the […]
Read MoreAuthors: Rachel Hadler, M.D.; Rebecca A. Aslakson, M.D., Ph.D. Anesthesiology September 2024, Vol. 141, 440–442. “[A]rming anesthesiologists with the tools to provide patient-centered, meaningful perioperative care has the potential to both increase goal-concordant care delivery and reduce clinician moral conflict, moral distress, and burnout.” Although preoperative “required reconsideration” for individuals with pre-existing treatment limitations (i.e., do-not-attempt-resuscitation or […]
Read MoreAnesthesiology September 2024, Vol. 141, A13–A15. Andexanet for factor Xa inhibitor–associated acute intracerebral hemorrhage. N Engl J Med 2024; 390:1745–55. PMID: 38749032. Patients sustaining acute intracerebral hemorrhage on anticoagulants are at increased risk for hematoma expansion. Factor Xa inhibitors are now widely used for chronic anticoagulation, and before the release of andexanet alfa, no specific reversal […]
Read More